GYRE – gyre therapeutics, inc. (US:NASDAQ)
Stock Stats
News
GYRE THERAPEUTICS: Kaskela Law Announces Investigation of Gyre Therapeutics, Inc. (GYRE) and Encourages Shareholders to Contact the Firm 
Gyre Therapeutics (GYRE) was downgraded by Zacks Research from "hold" to "strong sell".
Gyre Therapeutics Announces China's NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment [Yahoo! Finance]
Gyre Therapeutics Announces China’s NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Form ARS GYRE THERAPEUTICS, INC. For: Dec 31
Form DEF 14A GYRE THERAPEUTICS, INC. For: Jun 10
Form DEFA14A GYRE THERAPEUTICS, INC.
Form 8-K/A GYRE THERAPEUTICS, INC. For: Mar 02
Form PRE 14A GYRE THERAPEUTICS, INC. For: Jun 10
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.